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A B ST R AC T 
 
A R T IC LE D A T A 
Objective. This study investigates acute effects of various doses of 
Malathion on glucose homeostasis and insulin resistance in rat. 
Methods. Rats were randomly divided into four groups of 6 animals each. 
Corn oil was given orally to Group 1. Group 2, Group 3, and Group 4 
received malathion dissolved in corn oil via oral administration at the doses 
of 100, 200 and 400 mg/kg, respectively. 24 hours later the rats were 
sacrificed. 
Results. Acute administration of Malathion led to a decrease in serum butryl 
cholinesterase (BChE) levels at all doses tested. It also caused a significant 
increase in serum advanced glycation end products (AGEs), insulin, and 
TNF-α levels at all doses. Moreover, Malathion administration raised the 
liver ALT, AST and LDH, TNF-α, and glycogen levels in a dose dependent 
manner. It also led to a remarkable increase in pancreatic insulin levels at all 
doses. 
Conclusions. Acute administrations of Malathion affect glucose homeostasis 
in a dose dependent manner through its effects on the liver, serum, and 
pancreas. 
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Introduction  
Pesticides, which are widely used all over the world, 
are serious threats to the environment and public health. 
In many countries, pesticide poisoning has been 
reported to be the primary cause of morbidity and 
mortality. Organophosphates constitute 50% of the total 
recorded cases of pesticide poisoning amongst the 
pesticide family [1]. Malathion is one of the earliest 
developed organophosphate insecticides. Malathion (2- 
(dimethoxythiophosphorylthio) succinic acid diethyl ester) 
is a non-systemic, broad-spectrum organophosphate 
insecticide [2]. Its LD50 value for rat is 1375 mg/kg; 
NOEL value is 25 mg/kg/day for both rats and humans; 
ADI value is 0,2 mg/kg/day, and its LEL value is 
0,34mg/kg/day for humans [3]. Malathion, like other 
organophosphates, inhibits acetyl cholinesterase, which 
can be life-threating for many species of insects, animals, 
and humans [4]. Severe cholinesterase inhibition has been 
observed in people exposed to Malathion both acutely and 
chronically [2]. 
By affecting carbohydrate metabolism, Malathion may 
lead to inflammation, oxidative stress, and tissue damage. 
Earlier studies have suggested that Malathion could induce 
hyperglycemia through its impacts on glucose metabolism 
in the liver as well as skeletal muscle. It is also known to 
enhance glycogenolysis in the liver and skeletal muscle and 
gluconeogenesis in the liver [4]. It has been shown that 
acute Malathion poisoning results in enhanced glycogen 
deposition in liver within 6-24 h. [5].  
Literature indicates that chronic hyperglycemia affects 
insulin release and this pathophysiologic process, which is 
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called glucotoxicity, leads to insulin resistance [6]. 
Moreover, studies show that Malathion causes oxidative 
stress both in vivo and in vitro [7, 8]. In addition, 
organophosphates cause the formation of pro-
inflammatory cytokines, which are responsible for the 
activation of the Janus kinase and I-kappa B kinase beta 
(IKKβ) pathways [9].   
Subchronic administration of Malathion has been 
shown to influence glucose metabolism in rat muscle [4] 
and liver [10], but its acute administration influences 
hormonal control of glucose metabolism [11]. In addition, 
experimental studies have shown that chronic 
administration of Malathion increases glycogen [4, 12].   
The purpose of this study was to investigate the acute 
effects of Malathion administration on glucose metabolism 
at various doses and determine the mechanisms of insulin 
resistance as well as to illuminate the pathway of liver 
glycogenesis and gluconeogenesis. 
Materials and Methods 
This study was approved by University Local Ethics 
Board (code number G.U. ET. 14.015). All chemicals used 
in the study were purchased from SIGMA. In the study, 24 
Wistar albino (weight ~ 230 g) female rats were used. 
Animals were randomly divided into four groups of 6 
animals each. Group 1 (Control group) was given corn oil. 
Group 2, Group 3, and Group 4 were administered 100, 200 
and 400 mg/kg Malathion, respectively. Malathion was 
dissolved in corn oil and administered by oral gavage. All 
rats had access to standard rat feed and tap water ad libitum.  
The rats were sacrificed 24 hours after Malathion 
administration. Blood samples were taken via cardiac 
puncture under anesthesia and transferred to regular 
biochemistry tubes for serum tests. Blood samples were 
centrifuged at 3500 rpm at 4 0C for 10 minutes to separate 
serum. The liver and pancreas tissues were removed and 
washed with serum physiologic solution. Tissue samples 
were kept at -80 0C until homogenization. Then tissue 
samples were homogenized in ten volumes of Tris-HCl 
buffer using a homogenizer. The homogenates were then 
centrifuged at 3500 rpm and supernatants were separated 
and kept at -80 0C until analysis. 
Blood Glucose Test measured with Roche Diagnostics 
brand Cobas E411 autoanalyzer. As a test principle, 
hexokinase catalyzes formation of glucose-6-phosphate by 
using ATP. Glucose-6-phosphate is oxidized to gluconate-
6-phosphate in the presence of NADP. During the reaction, 
the rate of NADPH formation is directly proportional to the 
glucose concentration and is measured photometrically. 
Results are expressed as mg/dL. Serum BChE activity was 
measured with Roche Diagnostics brand Cobas E411 model 
autoanalyzer. ChE catalyzes the hydrolysis of 
butyrylthiocholine to thiolcholine and butyrate. Thiolcholine 
reduces yellow (III) hexacyanoferrite to colorless 
hexacyanoferrate (II). This reduction is measured 
photometrically. Results are expressed as U/L.  
Serum and pancreatic tissue insulin levels, serum and 
liver tissue TNF-α levels, and serum AGEs levels were 
measured using commercially available kits (Shanghai YH 
Biosearch). These kits use an enzyme-linked immune 
sorbent assay (ELISA) method based on biotin double 
antibody sandwich technology to assay rat insulin, rat TNF-
α, and rat AGEs. We added samples to the appropriate wells, 
which were pre-coated with insulin monoclonal antibodies, 
TNF-α monoclonal antibodies or AGEs monoclonal 
antibodies, respectively. After the incubation period, anti-
insulin, anti-TNF-α or anti-AGEs antibodies labelled with 
biotin and streptavidin-HRP were added to form an immune 
complex. Unbound enzyme molecules were removed after 
incubation via automated washing, followed by the addition 
of substrate A and B. The solution turned blue during the 
incubation and changed to yellow with the addition of acid 
solution in order to stop the reaction. Developed color 
intensity and concentrations are positively correlated. 
Results are expressed as mIU/L for insulin, ng/L for TNF-α 
and ng/mL for AGEs.  
The protein content of the liver tissues was measured by 
using the method described by Lowry et al [13]. Under 
alkaline environment, copper ion (Cu+2) forms a complex 
with the peptide bonds in the proteins and is reduced to Cu+1. 
Reduced copper and tyrosine, tryptophan, and cysteine 
amino acids in the side chain of proteins cause color 
formation by reducing the Folin-Phenol reagent. The 
intensity of the color formed is directly proportional to 
concentration of proteins, which was measured 
spectrophotometrically at 660 nm. Results are calculated as 
U/mg protein. 
Liver tissue supernatant’s ALT, AST and LDH activities 
were studied with Roche Diagnostics brand Cobas E411 
model autoanalyzer at 1:50 dilution ratio. ALT catalyzes the 
reaction between L-alanine and 2-oxoglutarate leading to 
pyruvate. Pyruvate is reduced by NADH to L-lactate. The 
rate of NADH oxidation is directly proportional to catalytic 
ALT activity. ALT activity is determined by measuring 
decrease in absorbance.  Results are expressed as U/mg 
protein.  
AST catalyzes the reaction between L-Aspartate and 2-
oxoglutarate leading to formation of L-glutamate and 
oxaloacetate. Oxaloacetate reacts with NADH in the 
presence of malate dehydrogenase (MDH) to form NAD+. 
The rate of NADH oxidation is directly proportional to the 
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catalytic AST activity, and AST activity is determined by 
measuring the decrease in absorbance. LDH catalyzes the 
conversion of L-lactate to pyruvate. In this reaction, the rate 
of NADH formation is directly proportional to the catalytic 
activity of LDH, and LDH activity is determined by 
measuring the increase in absorbance. 
Liver tissue weighing 500 mg was extracted with 1.5 ml 
of 30% KOH by incubating for 45 min at 95 0C and cooled. 
2 ml H2SO4 were added to the liver extract to adjust its pH, 
then 0.2 % anthrone solution was added to the mixture. The 
developed color was measured spectrophotometrically at 
620 nm. Results are expressed as mg/100 mg wet tissue [14]. 
Data Analyses 
Statistical analysis of the data was carried out using 
Kruskal Wallis test and the p ≤ 0.05 among the four groups. 
Mann-Whitney U test with Bonferroni correction was used 
to identify the significance level of the differences between 
pairs of two groups. Since 6 pairwise comparisons are 
possible for 4 groups, p value (0.05) was divided by 6 
according to Bonferroni correction (0.05 / 6 = 0.0083). 
Differences between two groups were considered 
significant when p<0.008. Correlation analysis was 
performed using the Spearman correlation. 
Results 
Acute administration of Malathion led to a significant 
decrease in serum BChE levels in Group 2, 3 and 4 
compared to Group 1 (p=0.002, p= 0.002, and p=0.002, 
respectively) (Figure 1). At 24h after administration of 
Malathion at doses of 100, 200 and 400 mg/kg, glucose 
levels did not change significantly (p= 0.352) in Groups 2, 
3 or 4 compared with Group 1 (Figure 2). 
 
Figure 1. Serum BChE Levels 
Figure 2. Serum Glucose Levels 
There was a significant increase in serum insulin levels 
in Group 4 compared to Group 1 (p= 0.002) (Figure 3). In 
addition, serum TNF-α levels of Groups 3 and 4 were 
remarkably higher compared with Group 1 (p=0.002 and 
p=0.002, respectively) (Figure 4). 
 
Figure 3. Serum Insulin Levels 
 
Figure 4. Serum TNF-alpha Levels 
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We found significant increases in serum AGEs levels 
in Groups 2 and 4 compared to Group 1 (p= 0.008, 
p=0.002) (Figure 5). Numeric results and significant 
differences of serum parameters are presented in Table 1.  
 
Figure 5. Serum AGEs Levels 
Pancreas insulin levels of Group 3 and Group 4 were 
significantly higher compared with Group 1 (p=0.008 and 
p=0.004, respectively) (Figure 6) (Table 2). 
 
Figure 6. Pancreas Insulin Levels 
There is a significant increase in the liver ALT (Figure 
7), AST (Figure 8) and LDH (Figure 9) in Group 3 and 
Group 4 compared to Group 1 and Group 2 (p<0.008).  
 
Figure 7. Liver ALT Levels 
 
Figure 8. Liver AST Levels 
Table 1. The numeric results and significant differences of serum parameters 
Groups/Parameters  
Group 1 (n=6) Group 2 (n=6) Group 3 (n=6) Group 4 (n=6) 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
BChE (U/L)  755±9.1 590.3±118.8 a 534±112.8 b 381.3±53.7 c 
Glucose (mg/dL) 249.00±36.6 203.83±31.6 223.6±17.99  256.33±25.2 
Insulin (mIU/L) 4.71±1.9 6.42 ±1.1 6.40 ±0.9 10.4±2.4 c 
TNF-α (ng/L) 70.5 ±14.5 89.2 ±12.1 97.9 ±4.8 b 167.7±81.3 c 
AGEs (ng/mL)  5.71 ± 1.44 8.98 ± 1.60 a 8.35 ± 2.63 11.42 ± 4.79 c 
BChE (Butryl Cholinesterase), TNF-α (tumor necrosis factor-alpha), AGEs (serum advanced glycation end products), SD (standard deviation), 
n (number of animals), a (significance p<0.008; difference between Group 1 and Group 2), b (significance p<0.008; difference between Group 
1 and Group 3), c (significance p<0.008; difference between Group 1 and Group 4)  
Table 2. The numeric results and significant differences of pancreas insulin level  
Groups/Parameters  
Group 1 (n=6) Group 2 (n=6) Group 3 (n=6) Group 4 (n=6) 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Insulin (mIU/L) 2.44 ± 1.82 2.07 ± 1.67  8.24 ± 5.42b 6.20 ± 2.35c 
SD (standard deviation), n (number of animals), a (significance p<0.008; difference between Group 1 and Group 2), b (significance p<0.008; 
difference between Group 1 and Group 3), c (significance p<0.008; difference between Group 1 and Group 4)  
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Figure 9. Liver LDH Levels 
A statistically significant increase in TNF-α levels was 
found in Group 4 compared to Group 1 (p=0.008) (Figure 
10).  
 
Figure 10. Liver TNF-alpha Levels 
 There was a statistically significant increase in 
glycogen levels in Group 2, Group 3, and Group 4 
compared to Group 1 (p= 0.004, p= 0.002, p= 0.004 
respectively) (Figure 11). Numeric results and significant 
differences of liver parameters are presented in Table 3. 
 
Figure 11. Liver Glycogen Levels 
According to the Spearman test, strong correlations 
were found between serum AGEs and insulin levels, BChE 
and serum insulin, insulin and TNF-α levels, and BChE and 
TNF-α (p<0.01) (Table 4). There was a positive correlation 
between serum insulin and pancreas insulin levels (p<0.05) 
and a strong negative correlation between BChE and 
pancreas insulin (p<0.001). We also found a positive 
correlation between serum insulin and liver glycogen 
(p<0.01) (Table 5). 
Discussions 
Malathion is an organophosphorus compound widely 
used in agriculture.  The widespread use of 
organophosphate-based pesticides is often criticized for the 
risks associated with their neurotoxicity [15]. 
Neurotoxicity results in mitochondrial damage, ROS 
production, and DNA fragmentation in the cell [16]. 
Malathion induces toxicity via its bioactive analogue 
malaoxon [17]. There are accidental and/or suicidal 
exposure cases to high doses in the literature [18, 19]. In 
addition, workers in agriculture may also be exposed to 
such pesticides [20]. Studies indicate that acute and/or 
chronic exposure to organophosphates induces 
hyperglycaemia [4, 5]. 
Table 3. The numeric results and significant differences of liver parameters  
Groups/Parameters  
Group 1 (n=6) Group 2 (n=6) Group 3 (n=6) Group 4 (n=6) 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
ALT (U/mg pro.) 9.2 ± 2.4 9.3 ± 2.3 15.1 ± 2.4 b,d 15 ± 3.8c,e  
AST (U/mg pro.) 15.8 ± 2.9 15 ± 2.5 24.4 ± 7 b,d 24.5 ± 7.1c,e 
LDH (U/mg pro.) 26.7 ± 4.7 23.9 ± 7.6 41.5 ± 11b,d 41.7 ± 9.3 c,e  
TNF-α (ng/L) 277 ± 60.8 333.7 ± 32.2 353.8 ± 50.6 406.2 ± 85.7c 
Glycogen(mg/100mg) 4.3 ± 0.4 6.2 ± 1.5a 7 ± 0.8b 5.7 ± 1c 
ALT (Alanine Aminotransferase), AST (Aspartate Aminotransferase), LDH (Lactate Dehydrogenase, TNF-α (tumor necrosis factor-alpha), SD 
(standard deviation), n (number of animals), a (significance p<0.008; difference between Group 1 and Group 2), b (significance p<0.008; difference 
between Group 1 and Group 3), c (significance p<0.008; difference between Group 1 and Group 4), d (significance p<0.008; difference between 
Group 2 and Group 3), e (significance p<0.008; difference between Group 2 and Group 4) 
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Subchronic administration of Malathion significantly 
decreases serum BChE activity. Consistent with this, we 
showed that acute administration of Malathion at 100, 200 
and 400 mg/kg to rats significantly inhibited BChE enzyme 
activity.  Mentioned doses of Malathion were chosen due 
to their acute toxic effects, 100 mg/kg, which is known as 
toxic dose, 400 mg/kg, plateau level (70% inhibition of 
cholinesterase), and 200 mg/kg, considered an 
intermediate value [21]. 
Like fructose-induction [22], many studies have 
suggested that organophosphate pesticides have effects on 
glucose homeostasis. For example, glucose homeostasis 
has led to changes in liver glucose production, which is 
thought to have been altered by gluconeogenesis in 
Malathion toxicity [23]. In our study, differences between 
glucose levels of groups were found to be insignificant 
(p>0.008). Although the differences between the groups in 
our study was not statistically significant, we believe 
further investigation is required, as other studies have 
concluded that hyperglycemia might occur as a result of 
Malathion treatment [24]. In this context, a slight increase 
in blood glucose levels of Group 4 and no significant 
changes in blood glucose levels of Group 2 and Group 3 
may be due to elevated insulin levels. We think that 
hyperglycemia may occur if the dose and/or exposure time 
were increased. 
In our study, there was a significant increase in serum 
insulin levels in Group 4 compared to the control group. 
Hyperinsulinemia has been reported with impaired glucose 
homeostasis after acute exposure to organophosphate [25].  
It is emphasized that reactive oxygen species (ROS) play 
an active role in the pathophysiology of insulin resistance. 
Some researchers have also mentioned that ROS led to 
insulin resistance by preventing threonine phosphatase 
activity [26]. In this study, the levels of serum AGEs were 
examined and differences were observed between the 
control group and the test groups. However, a statistically 
significant change was found in Group 2 and Group 4 
compared to Group 1. Recent studies demonstrated that 
AGEs have a crucial role in complications developing in 
Table 4. Correlation analyses among serum parameters 
Parameters  Glucose Insulin  BChE AGEs TNF-α 
Glucose  
r 1.000 0.273 -0.043 -0.212 0.092 
p  . 0.208 0.845 0.332 0.678 
n 24 24 24 24 24 
Insulin 
r 0.273 1.000 -0.529 0.542 0.613 
p 0.208 . 0.008** 0.006** 0.001** 
n 24 24 24 24 24 
BChE 
r -0.043 -0.529 1.000 -0.586 -0.843 
p 0.845 0.008** . 0.003** 0.000** 
n 24 24 24 24 24 
AGEs 
r -0.212 0.542 -0.586 1.000 0.695 
p 0.332 0.006** 0.003** . 0.000** 
n 24 24 24 24 24 
TNF-α 
r 0.092 0.613 -0.843 0.695 1.000 
p 0.678 0.001** 0.000** 0.000** . 
n 24 24 24 24 24 
BChE (Butryl Cholinesterase), AGEs (serum advanced glycation end products), TNF-α (tumor necrosis factor-alpha), r (Correlation 
coefficient), p (significance), n (number of animals), ** (significance correlation at the 0.01 level (2-tailed)) 
Table 5. Correlation analyses between some serum parameters and pancreas insulin, liver glycogen 
Parameters  Serum insulin BChE Pancreas insulin Glycogen 
Serum insulin 
r 1.000 -0.529 0.485 0.472 
p  . 0.008** 0.016* 0.020* 
n 24 24 24 24 
BChE 
r -0.529 1,000 -0.527 -0.367 
p  0.008** . 0.008** 0.078 
n 24 24 24 24 
Pancreas insulin  
r 0.485 -0.527 1,000 0.274 
p 0.016* 0.008** . 0.196 
n 24 24 24 24 
Glycogen  
r 0.472 -0.367 0.274 1,000 
p 0.020* 0.078 0.196 . 
n 24 24 24 24 
BChE (Butryl Cholinesterase), ), r (Correlation coefficient), p (significance), n (number of animals), ** (significance correlation at the 0.01 
level  
(2-tailed)), * (significance correlation at the 0.05 level (2-tailed)) 
Acute Effects of Malathion on Glucose Homeostasis in Rat 
 91 
diabetes, liver disorders, neurodegenerative disease, and 
even in some types of cancer [8]. It is proposed that 
enhanced levels of AGEs may lead to insulin resistance or 
Type 2 Diabetes by increasing oxidative stress, 
inflammation, and/or affecting insulin receptor substrate 1 
(IRS-1) [27]. In line with this, we found a positive 
correlation between serum insulin and AGEs levels 
(p<0.01).  
Many studies have hypothesized that insulin resistance 
is caused by inflammation and oxidative stress on glucose 
metabolism. According to these hypotheses, ROS leads to 
activation of serine/threonine kinases which inhibits of 
phosphorylation IRS-1 and this may lead to insulin 
resistance [8].  
In addition to an increase in serum insulin, we found 
that pancreatic insulin levels were also significantly 
elevated in Group 4 compared to Group 1. Furthermore, the 
insulin levels of Group 3 and Group 4 were significantly 
higher than those of Group 2 (p<0.008). These results 
suggested that insulin production may increase to maintain 
glucose homeostasis. This study revealed that there is a 
correlation between serum insulin levels and pancreatic 
insulin levels (p<0.05). It is suggested that subchronic 
exposure of Malathion stimulates insulin secretion by 
pancreatic beta cells through inhibition of AChE activity 
[28]. Inhibition of AChE activity causes accumulation of 
acetylcholine that activates cholinergic receptors leading to 
an increase in insulin secretion. In a similar way, we 
observed that there are strong negative correlations 
between serum BChE and serum insulin levels as well as 
pancreatic insulin levels (p<0.01). Thus, our study revealed 
this relationship using acute doses of Malathion. 
Several studies have shown that organophosphate 
compounds cause an increase in levels of TNF-α and IL-6, 
which in turn have a significant role in inflammation. For 
example, organophosphate compounds such as Malathion 
and diazinon have been shown to increase these cytokines 
[29, 30]. In this study, a statistically significant increase in 
both serum and liver TNF-α levels were observed in Group 
4 compared to the control group (p <0.008). Although, 
there were increases in TNF-α levels in Group 2 and 3 as 
well, they were not significant.  
Literature has emphasized that Malathion intoxication 
increases insulin secretion, parallel to an increase in blood 
glucose levels [31, 32]. Subchronic Malathion exposure 
studies have shown that insulin resistance is related to 
oxidative damage and inflammation [33]. In this study we 
found a strong correlation between serum TNF-α levels 
and serum insulin levels (p<0.01), consistent with previous 
studies. 
Experimental studies have shown that chronic 
administration of Malathion modifies liver carbohydrate 
metabolism and increases the rate of liver glycogen 
synthesis [4, 12]. 24 hours after administration of 50 and 
100 mg/kg Malathion, the amount of liver glycogen was 
increased [5]. In another study, Malathion increased liver 
glycogen synthesis within 2 hours after an acute dose of 
400 mg/kg, the synthetic process peaked after 12 hours, 
and remained the same for the following 24 hours [34]. 
This finding demonstrates that Malathion inhibits the 
activity of glycogen phosphorylase enzyme and 
subsequently activates the enzyme glycogen synthase, 
which acts as an antagonist of glycogen phosphorylase 
enzyme [12]. It is also well known that insulin activates the 
synthesis of glycogen both in muscle and liver tissues. This 
synthesis of glycogen is catalyzed by glycogen synthase, 
which is the key enzyme in the pathway of glycogen 
synthesis [35]. 
In this study a statistically significant increase in 
glycogen in Groups 2, 3, and 4, compared to group 1 
(p<0.008) was observed, in accordance with previous 
studies [5, 34]. We also found a positive correlation 
between serum insulin and liver glycogen (p<0.05) 
It has been observed that a chronic dose of diazinon, 
which is a member of the organophosphate chemical 
family, decreased liver ALT, AST and LDH activities and 
enhanced lipid peroxidation. This finding suggests that 
lipid peroxidation damages the integrity of cellular 
membranes, resulting in leakage of cytoplasmic enzymes 
into the blood [36]. In contrast, in our study, acute doses of 
Malathion significantly increased liver ALT, AST, and 
LDH activities in all groups. Our results showed that liver 
ALT, AST, and LDH activities of Groups 3 and 4 were 
higher than that of Groups 1 and 2 (p<0.008). This could 
be due to differences in dosage administration and also the 
period of exposure. This suggests that acute doses of 
organophosphates may not change the integrity of the 
cellular membrane.  
In another study, chlorpyryfos, a member of the 
organophosphate family, caused hyperglycemia and 
resulted in the activation of the gluconeogenesis pathway. 
Tyrosine aminotransferase (a glucogenic enzymes) also 
increased when an acute dose of chlorpryfos was 
administered [37]. Similarly, we propose that ALT, AST, 
and LDH (also glucogenic enzymes) could increase due to 
activation of the gluconeogenesis pathway. 
Conclusions 
According to our results, acute administration of 
Malathion influences glucose homeostasis, affecting the 
liver, serum, and pancreas in a dose dependent manner. 
Therefore, we suggest that necessary precautions be taken 
to protect the public from the damaging effects of 
organophosphates even after an acute exposure.  
We recommend that further studies be conducted to 
elucidate the exact mechanisms of actions of Malathion on 
glucose metabolism. After acute administration of 
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Malathion, it is also important to analyze the levels of all 
glycogenic enzymes, cytokines, and other biomolecules. 
Investigation of the relationship between insulin resistance, 
inflammation, oxidative stress and gluconeogenesis is also 
thought to be essential. 
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